Market cap
$527m
Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.
Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.
To date, the Company has funded its operations primarily with proceeds received from the sales of redeemable convertible preferred stock, public offerings of the Company’s common stock, private placements of the Company's common stock, debt financing, and through its collaboration agreements. As part of the collaboration, Betta Pharma made an upfront cash payment of $ 10.0 million to the Company and has agreed to make up to $ 357.0 million in aggregate milestone payments, plus tiered royalties on net sales of CFT8919 in Greater China. …C4 Therapeutics, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-11